Nonfood & Pharmacy
Rite Aid to Sell Majority of Pharmacy Assets, CVS Acquires 64 Stores
Rite Aid CVS Deal Moves Forward as 64 Stores Set for Acquisition
Bankruptcy Triggers Major Pharmacy Asset Transfer Across the U.S.
The Rite Aid CVS deal highlights a major shift in retail pharmacy. CVS will acquire 64 Rite Aid and Bartell Drugs stores.
Additionally, it will receive prescription files from over 600 Rite Aid locations across 15 states, expanding its national presence.
CVS Expands as Rite Aid Exits Key Markets
Rite Aid recently filed for Chapter 11 bankruptcy again, aiming to sell most of its pharmacy-related assets to major competitors.
The transfer includes prescription records, inventory, and patient data, common in pharmacy transitions during store closures.
Only 64 physical store locations are part of the Rite Aid CVS deal. The rest involve prescription files from stores in multiple states.
These include California, Pennsylvania, New York, Maryland, and more—significantly widening CVS’s customer footprint.
CVS Assures Smooth Patient Transition
CVS confirmed it will ensure a seamless transition for Rite Aid customers and patients, avoiding service interruptions.
The company stated that all current pharmacy services will continue during the handoff and that store operations will remain open.
CVS has also opened employment opportunities for Rite Aid employees interested in joining its expanding workforce.
Meanwhile, a CVS spokesperson said, “We are working to protect patient access throughout this important transition phase.”
Industry Shift: Rite Aid Winds Down, CVS Ramps Up
As of the recent bankruptcy filing, Rite Aid had 1,240 locations, with most expected to be affected by asset sales.
CEO Matt Schroeder told employees the company will likely cease to exist after the sales conclude, expected by early June.
A court hearing on May 21 will approve the sales, which include CVS, Walgreens, Kroger, Giant Eagle, and Albertsons as buyers.
However, CVS stands out in this shift, gaining the most physical stores and a wide range of prescription data.
This strategic move could solidify CVS’s dominance in the pharmacy retail market during a period of industry consolidation.